Get the initial IRB submission right the first time.
Initial IRB Submission: 7 Fundamentals of Success
Related Posts
Obe-Cel Achieves High Response Rates, Durable Outcomes in r/r B-Cell Acute Lymphoblastic Leukemia
Credit: Arif Biswas | stock.adobe.com Obecabtagene autoleucel (obe-cel; Autolus Therapeutics)—a CD19 chimeric antigen receptor (CAR) T-cell therapy—produced high response rates and durable outcomes with limited […]
How We Are Deepening Relationships With Patients
Susan Campbell, Global Head of Patient Recruitment, ICON Tinaya Gray, Global Head, Diversity in Clinical Trials, ICON Patients are more than participants; they are partners […]
The Current State of Diversity in Randomized Clinical Trials for Peripheral Artery Disease
Image Credit: © Jakub Krechowicz – stock.adobe.com A recent study published by the National Library of Medicine reviewed diversity in randomized clinical trials (RCTs) for […]